These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26713059)

  • 1. Early Caffeine Use in Very Low Birth Weight Infants and Neonatal Outcomes: A Systematic Review and Meta-Analysis.
    Park HW; Lim G; Chung SH; Chung S; Kim KS; Kim SN
    J Korean Med Sci; 2015 Dec; 30(12):1828-35. PubMed ID: 26713059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.
    Puia-Dumitrescu M; Smith PB; Zhao J; Soriano A; Payne EH; Harper B; Bendel-Stenzel E; Moya F; Chhabra R; Ku L; Laughon M; Wade KC;
    J Pediatr; 2019 Aug; 211():27-32.e1. PubMed ID: 31101409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis.
    Chen J; Jin L; Chen X
    Biomed Res Int; 2018; 2018():9061234. PubMed ID: 30671477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of prevention of caffeine citrate on cytokine profile and bronchopulmonary dysplasia in preterm infants with apnea.
    Kou C; Han D; Li Z; Wu W; Liu Z; Zhang Y; Gao Z
    Minerva Pediatr; 2020 Apr; 72(2):95-100. PubMed ID: 30961342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High versus standard dose caffeine for apnoea: a systematic review.
    Vliegenthart R; Miedema M; Hutten GJ; van Kaam AH; Onland W
    Arch Dis Child Fetal Neonatal Ed; 2018 Nov; 103(6):F523-F529. PubMed ID: 29437799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of early caffeine administration and neonatal outcomes in very preterm neonates.
    Lodha A; Seshia M; McMillan DD; Barrington K; Yang J; Lee SK; Shah PS;
    JAMA Pediatr; 2015 Jan; 169(1):33-8. PubMed ID: 25402629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants.
    Taha D; Kirkby S; Nawab U; Dysart KC; Genen L; Greenspan JS; Aghai ZH
    J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1698-702. PubMed ID: 24479608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between caffeine citrate exposure and necrotizing enterocolitis in preterm infants.
    Lampkin SJ; Turner AM; Lakshminrusimha S; Mathew B; Brown J; Fominaya CE; Johnson KK
    Am J Health Syst Pharm; 2013 Apr; 70(7):603-8. PubMed ID: 23515513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effect of early or late administration of caffeine citrate in prevention and treatment of apnea in very low birth weight infants].
    Feng Y; Cheng R; Zhao L; Chen X; Mao XN; Qiu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Dec; 20(12):979-984. PubMed ID: 30572984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants.
    Schmidt B; Roberts R; Millar D; Kirpalani H
    Neonatology; 2008; 93(4):284-7. PubMed ID: 18525211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity.
    Vatlach S; Arand J; Engel C; Poets CF
    Neonatology; 2014; 105(2):108-11. PubMed ID: 24335098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect and safety of different maintenance doses of caffeine citrate in treatment of apnea in very low birth weight preterm infants: a prospective randomized controlled trial].
    Zhang X; Zhang HT; Lyu Y; Wang LF; Yang ZY
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jun; 21(6):558-561. PubMed ID: 31208509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is bronchopulmonary dysplasia and does caffeine prevent it?
    Jensen EA
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101176. PubMed ID: 33168465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?
    Saroha V; Patel RM
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101178. PubMed ID: 33168464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
    J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotic Supplementation in Preterm Infants Does Not Affect the Risk of Bronchopulmonary Dysplasia: A Meta-Analysis of Randomized Controlled Trials.
    Villamor-Martínez E; Pierro M; Cavallaro G; Mosca F; Kramer B; Villamor E
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29088103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiogenic Necrotizing Enterocolitis: A Clinically Distinct Entity from Classical Necrotizing Enterocolitis.
    Siano E; Lauriti G; Ceccanti S; Zani A
    Eur J Pediatr Surg; 2019 Feb; 29(1):14-22. PubMed ID: 30112744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.